In this interview, Dr Vladislav Sandler, CEO of Hemogenyx Pharma discussed the latest news that CDX Antibody is effective against ALL in vitro, how this could breakthrough in blood cancer treatment. He also addressed the stock market’s perception of his company up until this point.
Zakmir.com is a purely journalistic website – Zak Mir is a member of the National Union of Journalists. There is no intention here of providing financial advice. It is recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.